Scholar Rock (NASDAQ:SRRK – Get Rating) issued its quarterly earnings results on Tuesday. The company reported ($0.49) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.57) by $0.08, Briefing.com reports. During the same period last year, the business earned ($0.21) earnings per share. Scholar Rock Trading Down 2.0 % NASDAQ:SRRK traded […]
Scholar Rock Holding Co. (NASDAQ:SRRK – Get Rating) has been given an average recommendation of “Buy” by the six ratings firms that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have updated their coverage on the stock […]
Shares of Scholar Rock Holding Co. (NASDAQ:SRRK – Get Rating) have been given a consensus recommendation of “Buy” by the six ratings firms that are currently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued a report […]
Aura Biosciences (NASDAQ:AURA – Get Rating) and Scholar Rock (NASDAQ:SRRK – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation. Profitability This table compares Aura Biosciences and Scholar Rock’s […]
Scholar Rock Holding Co. (NASDAQ:SRRK – Get Rating) has been given an average rating of “Buy” by the six brokerages that are covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock […]